Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 102 | 2024 | 11206 | 4.570 |
Why?
|
Prostate-Specific Antigen | 14 | 2024 | 2483 | 1.360 |
Why?
|
Polymorphism, Single Nucleotide | 51 | 2024 | 16029 | 1.330 |
Why?
|
Kallikreins | 3 | 2024 | 221 | 1.180 |
Why?
|
Genome-Wide Association Study | 22 | 2023 | 12774 | 1.060 |
Why?
|
Urinary Bladder, Overactive | 2 | 2024 | 117 | 0.970 |
Why?
|
Prostate | 11 | 2023 | 1781 | 0.940 |
Why?
|
Genetic Predisposition to Disease | 34 | 2024 | 18048 | 0.900 |
Why?
|
Selenium | 4 | 2016 | 419 | 0.820 |
Why?
|
Urinary Incontinence, Stress | 1 | 2024 | 182 | 0.780 |
Why?
|
Pregnancy-Associated Plasma Protein-A | 1 | 2021 | 61 | 0.760 |
Why?
|
Serine Endopeptidases | 5 | 2023 | 1032 | 0.700 |
Why?
|
Insulin-Like Growth Factor I | 4 | 2023 | 1943 | 0.640 |
Why?
|
Chromosomes, Human, Pair 8 | 6 | 2024 | 453 | 0.620 |
Why?
|
Fecal Incontinence | 1 | 2019 | 242 | 0.550 |
Why?
|
Metformin | 2 | 2014 | 914 | 0.510 |
Why?
|
Urinary Incontinence | 1 | 2019 | 494 | 0.490 |
Why?
|
PTEN Phosphohydrolase | 5 | 2021 | 1119 | 0.480 |
Why?
|
Metabolomics | 3 | 2021 | 1675 | 0.460 |
Why?
|
Follow-Up Studies | 25 | 2024 | 39430 | 0.460 |
Why?
|
Genotype | 25 | 2024 | 13047 | 0.460 |
Why?
|
Selenoprotein P | 1 | 2012 | 33 | 0.420 |
Why?
|
Male | 107 | 2024 | 364781 | 0.420 |
Why?
|
Genetic Variation | 12 | 2016 | 6610 | 0.390 |
Why?
|
Case-Control Studies | 32 | 2025 | 22293 | 0.390 |
Why?
|
Gene Expression Profiling | 8 | 2023 | 9507 | 0.380 |
Why?
|
Oncogene Proteins, Fusion | 7 | 2024 | 1614 | 0.370 |
Why?
|
Colonic Neoplasms | 2 | 2020 | 2544 | 0.370 |
Why?
|
Germ-Line Mutation | 5 | 2024 | 1884 | 0.370 |
Why?
|
Genetic Markers | 5 | 2022 | 2604 | 0.360 |
Why?
|
Aged | 64 | 2025 | 171520 | 0.340 |
Why?
|
Selenoproteins | 2 | 2016 | 216 | 0.330 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2019 | 2910 | 0.320 |
Why?
|
Repressor Proteins | 1 | 2019 | 2987 | 0.310 |
Why?
|
Prostatectomy | 8 | 2020 | 1840 | 0.310 |
Why?
|
Humans | 118 | 2025 | 768451 | 0.300 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2009 | 419 | 0.290 |
Why?
|
Neoplasm Staging | 10 | 2021 | 11249 | 0.290 |
Why?
|
Risk Factors | 36 | 2025 | 74915 | 0.280 |
Why?
|
Nerve Tissue Proteins | 1 | 2019 | 4417 | 0.270 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 3 | 2023 | 415 | 0.270 |
Why?
|
Tissue Array Analysis | 4 | 2021 | 551 | 0.260 |
Why?
|
Prospective Studies | 27 | 2024 | 54914 | 0.250 |
Why?
|
Middle Aged | 55 | 2025 | 223418 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2024 | 8635 | 0.240 |
Why?
|
Endometrial Neoplasms | 2 | 2025 | 1382 | 0.240 |
Why?
|
Twins, Dizygotic | 2 | 2016 | 236 | 0.230 |
Why?
|
Disease Progression | 11 | 2024 | 13655 | 0.230 |
Why?
|
Genetic Loci | 4 | 2021 | 2630 | 0.220 |
Why?
|
Prognosis | 13 | 2024 | 30028 | 0.220 |
Why?
|
Urinary Incontinence, Urge | 1 | 2024 | 50 | 0.220 |
Why?
|
Proportional Hazards Models | 10 | 2024 | 12561 | 0.220 |
Why?
|
RNA, Messenger | 4 | 2017 | 12813 | 0.220 |
Why?
|
Organic Anion Transporters | 1 | 2024 | 101 | 0.210 |
Why?
|
Twins, Monozygotic | 2 | 2016 | 472 | 0.210 |
Why?
|
Receptors, Calcium-Sensing | 2 | 2015 | 318 | 0.210 |
Why?
|
Cohort Studies | 19 | 2024 | 41797 | 0.200 |
Why?
|
Choline | 1 | 2024 | 518 | 0.200 |
Why?
|
Superoxide Dismutase | 2 | 2015 | 596 | 0.190 |
Why?
|
DNA Repair-Deficiency Disorders | 1 | 2021 | 37 | 0.190 |
Why?
|
Vitamin D | 5 | 2024 | 3311 | 0.180 |
Why?
|
Hypoglycemic Agents | 1 | 2014 | 3111 | 0.180 |
Why?
|
Risk | 9 | 2021 | 9642 | 0.180 |
Why?
|
Body Mass Index | 6 | 2025 | 13030 | 0.180 |
Why?
|
Aneuploidy | 1 | 2024 | 572 | 0.180 |
Why?
|
Aged, 80 and over | 19 | 2022 | 59680 | 0.180 |
Why?
|
Odds Ratio | 8 | 2025 | 9687 | 0.170 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2022 | 554 | 0.170 |
Why?
|
Multifactorial Inheritance | 3 | 2023 | 1421 | 0.160 |
Why?
|
Confidence Intervals | 3 | 2021 | 2932 | 0.160 |
Why?
|
Serine Proteases | 1 | 2018 | 50 | 0.160 |
Why?
|
Linkage Disequilibrium | 8 | 2012 | 1998 | 0.150 |
Why?
|
Age Factors | 4 | 2025 | 18478 | 0.150 |
Why?
|
Receptors, Calcitriol | 3 | 2024 | 361 | 0.150 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2024 | 3253 | 0.150 |
Why?
|
Quality of Life | 1 | 2019 | 13497 | 0.150 |
Why?
|
Body Height | 2 | 2021 | 1568 | 0.150 |
Why?
|
Urinary Bladder | 1 | 2024 | 1160 | 0.140 |
Why?
|
Drug Eruptions | 1 | 2020 | 335 | 0.140 |
Why?
|
Environment | 1 | 2023 | 1126 | 0.140 |
Why?
|
Genetic Association Studies | 4 | 2021 | 2742 | 0.140 |
Why?
|
DNA Modification Methylases | 1 | 2018 | 210 | 0.140 |
Why?
|
Diabetes Mellitus | 2 | 2025 | 5887 | 0.140 |
Why?
|
Transurethral Resection of Prostate | 1 | 2017 | 81 | 0.140 |
Why?
|
Extracellular Matrix Proteins | 1 | 2021 | 835 | 0.140 |
Why?
|
Squalene Monooxygenase | 1 | 2016 | 11 | 0.140 |
Why?
|
Inheritance Patterns | 1 | 2019 | 341 | 0.140 |
Why?
|
Glutathione Peroxidase | 2 | 2016 | 259 | 0.130 |
Why?
|
Neurosecretory Systems | 1 | 2017 | 223 | 0.130 |
Why?
|
Risk Assessment | 13 | 2024 | 24311 | 0.130 |
Why?
|
Chromosome Mapping | 5 | 2018 | 4622 | 0.130 |
Why?
|
Quantitative Trait Loci | 3 | 2019 | 2127 | 0.130 |
Why?
|
DNA Repair Enzymes | 1 | 2018 | 347 | 0.130 |
Why?
|
Haplotypes | 8 | 2018 | 2725 | 0.130 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2019 | 876 | 0.120 |
Why?
|
Neoplasm Invasiveness | 3 | 2021 | 3637 | 0.120 |
Why?
|
Molecular Epidemiology | 2 | 2014 | 473 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2019 | 10358 | 0.120 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2021 | 1660 | 0.120 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 3816 | 0.120 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 2 | 2023 | 126 | 0.120 |
Why?
|
Signal Transduction | 4 | 2024 | 23638 | 0.120 |
Why?
|
Breast Neoplasms | 9 | 2022 | 21156 | 0.110 |
Why?
|
Genes, BRCA1 | 2 | 2010 | 755 | 0.110 |
Why?
|
Survival Analysis | 4 | 2015 | 10125 | 0.110 |
Why?
|
Electroretinography | 1 | 2016 | 524 | 0.110 |
Why?
|
Interleukin-4 | 1 | 2018 | 1158 | 0.110 |
Why?
|
Catalase | 1 | 2014 | 219 | 0.110 |
Why?
|
Genes, myc | 2 | 2017 | 391 | 0.110 |
Why?
|
Models, Statistical | 2 | 2021 | 5103 | 0.110 |
Why?
|
Translocation, Genetic | 1 | 2018 | 1395 | 0.100 |
Why?
|
Cell Cycle Proteins | 1 | 2024 | 3463 | 0.100 |
Why?
|
Adult | 22 | 2025 | 223542 | 0.100 |
Why?
|
Epigenomics | 1 | 2018 | 956 | 0.100 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2018 | 783 | 0.100 |
Why?
|
DNA Repair | 1 | 2021 | 2051 | 0.100 |
Why?
|
Sweden | 3 | 2024 | 1382 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2017 | 998 | 0.100 |
Why?
|
Stromal Cells | 1 | 2017 | 1335 | 0.100 |
Why?
|
Vitamin E | 1 | 2016 | 873 | 0.100 |
Why?
|
Receptors, Adiponectin | 1 | 2011 | 82 | 0.090 |
Why?
|
Metabolome | 1 | 2018 | 1009 | 0.090 |
Why?
|
Mendelian Randomization Analysis | 3 | 2023 | 1036 | 0.090 |
Why?
|
Early Detection of Cancer | 3 | 2023 | 3230 | 0.090 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6856 | 0.090 |
Why?
|
Prostatic Secretory Proteins | 1 | 2010 | 24 | 0.090 |
Why?
|
Promoter Regions, Genetic | 2 | 2021 | 5803 | 0.090 |
Why?
|
Receptor, IGF Type 1 | 1 | 2013 | 384 | 0.090 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2020 | 2884 | 0.090 |
Why?
|
Cholesterol | 2 | 2018 | 2910 | 0.090 |
Why?
|
Energy Intake | 1 | 2018 | 2141 | 0.090 |
Why?
|
Neoplasms | 2 | 2016 | 22386 | 0.090 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2010 | 60 | 0.090 |
Why?
|
Genetics, Population | 2 | 2006 | 946 | 0.090 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2010 | 277 | 0.090 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3939 | 0.080 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2204 | 0.080 |
Why?
|
Logistic Models | 3 | 2021 | 13324 | 0.080 |
Why?
|
Gene Fusion | 1 | 2012 | 356 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2017 | 3794 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2465 | 0.080 |
Why?
|
Adenocarcinoma | 2 | 2018 | 6400 | 0.080 |
Why?
|
ROC Curve | 1 | 2016 | 3624 | 0.080 |
Why?
|
Endoribonucleases | 1 | 2010 | 229 | 0.080 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 506 | 0.080 |
Why?
|
Double-Blind Method | 2 | 2013 | 12450 | 0.070 |
Why?
|
Paraffin Embedding | 2 | 2020 | 306 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 2018 | 2819 | 0.070 |
Why?
|
Toll-Like Receptor 4 | 1 | 2011 | 586 | 0.070 |
Why?
|
Epithelial Cells | 2 | 2017 | 3697 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2018 | 2901 | 0.070 |
Why?
|
Molecular Sequence Annotation | 2 | 2021 | 526 | 0.070 |
Why?
|
DNA-Binding Proteins | 1 | 2024 | 9623 | 0.070 |
Why?
|
Sequence Tagged Sites | 1 | 2006 | 96 | 0.070 |
Why?
|
Alleles | 5 | 2024 | 6890 | 0.070 |
Why?
|
Mutation, Missense | 4 | 2010 | 2594 | 0.070 |
Why?
|
Incidence | 6 | 2024 | 21552 | 0.070 |
Why?
|
Gene Dosage | 1 | 2010 | 1221 | 0.070 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2007 | 306 | 0.070 |
Why?
|
Immunohistochemistry | 4 | 2014 | 11138 | 0.060 |
Why?
|
Antioxidants | 1 | 2014 | 1678 | 0.060 |
Why?
|
DNA | 1 | 2019 | 7213 | 0.060 |
Why?
|
Adiponectin | 1 | 2011 | 1118 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2017 | 7599 | 0.060 |
Why?
|
Obesity | 3 | 2018 | 13065 | 0.060 |
Why?
|
Survival Rate | 3 | 2020 | 12875 | 0.060 |
Why?
|
C-Reactive Protein | 2 | 2014 | 3854 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2019 | 2915 | 0.060 |
Why?
|
Hypertension | 1 | 2024 | 8611 | 0.060 |
Why?
|
Androgen Antagonists | 2 | 2024 | 1418 | 0.060 |
Why?
|
United States | 8 | 2025 | 73121 | 0.060 |
Why?
|
Precancerous Conditions | 1 | 2010 | 988 | 0.060 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2007 | 635 | 0.060 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2024 | 350 | 0.050 |
Why?
|
BRCA1 Protein | 1 | 2010 | 1158 | 0.050 |
Why?
|
Female | 16 | 2025 | 396943 | 0.050 |
Why?
|
Europe | 2 | 2024 | 3439 | 0.050 |
Why?
|
Trans-Activators | 1 | 2012 | 2858 | 0.050 |
Why?
|
Receptor, Muscarinic M3 | 1 | 2022 | 37 | 0.050 |
Why?
|
Marital Status | 1 | 2024 | 426 | 0.050 |
Why?
|
Receptors, Purinergic | 1 | 2022 | 66 | 0.050 |
Why?
|
Contraceptives, Oral | 1 | 2025 | 562 | 0.050 |
Why?
|
Calcium | 1 | 2015 | 5793 | 0.050 |
Why?
|
Time Factors | 3 | 2019 | 40271 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11843 | 0.050 |
Why?
|
Menarche | 1 | 2025 | 538 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4906 | 0.050 |
Why?
|
Gene Expression | 1 | 2014 | 7605 | 0.050 |
Why?
|
Biopsy | 2 | 2024 | 6816 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2023 | 314 | 0.050 |
Why?
|
Life Style | 2 | 2024 | 3929 | 0.050 |
Why?
|
Cholinergic Antagonists | 1 | 2022 | 167 | 0.050 |
Why?
|
Parity | 1 | 2025 | 939 | 0.050 |
Why?
|
Receptors, Cholinergic | 1 | 2022 | 244 | 0.050 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2023 | 268 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2016 | 20231 | 0.050 |
Why?
|
Genes, BRCA2 | 1 | 2004 | 592 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 4948 | 0.050 |
Why?
|
TRPV Cation Channels | 1 | 2022 | 244 | 0.040 |
Why?
|
Stathmin | 1 | 2020 | 70 | 0.040 |
Why?
|
Bone Neoplasms | 1 | 2012 | 2562 | 0.040 |
Why?
|
Fanconi Anemia | 1 | 2021 | 327 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6978 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 433 | 0.040 |
Why?
|
Receptors, Androgen | 1 | 2004 | 1084 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15460 | 0.040 |
Why?
|
Medical History Taking | 1 | 2022 | 776 | 0.040 |
Why?
|
Registries | 3 | 2024 | 8373 | 0.040 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2018 | 313 | 0.040 |
Why?
|
Diet, Mediterranean | 1 | 2024 | 747 | 0.030 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2018 | 431 | 0.030 |
Why?
|
Hawaii | 2 | 2006 | 101 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2022 | 81834 | 0.030 |
Why?
|
Androgens | 1 | 2024 | 1285 | 0.030 |
Why?
|
Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.030 |
Why?
|
Thioredoxin Reductase 1 | 1 | 2016 | 32 | 0.030 |
Why?
|
Selenium-Binding Proteins | 1 | 2016 | 18 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2021 | 12096 | 0.030 |
Why?
|
Seasons | 2 | 2012 | 1526 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2020 | 2477 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2017 | 245 | 0.030 |
Why?
|
Fluorouracil | 1 | 2020 | 1656 | 0.030 |
Why?
|
Smoking | 2 | 2025 | 9099 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2010 | 5342 | 0.030 |
Why?
|
Phospholipids | 1 | 2018 | 783 | 0.030 |
Why?
|
Germ Cells | 1 | 2018 | 641 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2024 | 17149 | 0.030 |
Why?
|
Norway | 1 | 2016 | 501 | 0.030 |
Why?
|
Finland | 1 | 2016 | 609 | 0.030 |
Why?
|
DNA Damage | 1 | 2024 | 2461 | 0.030 |
Why?
|
Social Class | 1 | 2023 | 2000 | 0.030 |
Why?
|
Trypsin Inhibitor, Kazal Pancreatic | 1 | 2014 | 30 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2015 | 267 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2019 | 13589 | 0.030 |
Why?
|
Social Support | 1 | 2024 | 2195 | 0.030 |
Why?
|
Microsatellite Repeats | 2 | 2007 | 784 | 0.030 |
Why?
|
Phenotype | 3 | 2019 | 16712 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2017 | 4931 | 0.030 |
Why?
|
Cell Differentiation | 1 | 2011 | 11674 | 0.030 |
Why?
|
Denmark | 1 | 2016 | 778 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2023 | 2119 | 0.030 |
Why?
|
Watchful Waiting | 1 | 2017 | 496 | 0.030 |
Why?
|
Epithelium | 1 | 2017 | 1610 | 0.030 |
Why?
|
Retinoid X Receptor alpha | 1 | 2012 | 22 | 0.030 |
Why?
|
Mice | 4 | 2024 | 82045 | 0.030 |
Why?
|
25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2012 | 57 | 0.030 |
Why?
|
Steroid Hydroxylases | 1 | 2012 | 93 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1797 | 0.020 |
Why?
|
Biological Transport | 1 | 2016 | 2089 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2015 | 9425 | 0.020 |
Why?
|
Vitamin D-Binding Protein | 1 | 2012 | 130 | 0.020 |
Why?
|
Testosterone | 1 | 2022 | 2493 | 0.020 |
Why?
|
Triglycerides | 1 | 2018 | 2465 | 0.020 |
Why?
|
Australia | 1 | 2014 | 1264 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2018 | 2358 | 0.020 |
Why?
|
Waist Circumference | 1 | 2013 | 935 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2024 | 5808 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7863 | 0.020 |
Why?
|
Self Report | 1 | 2021 | 3771 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2531 | 0.020 |
Why?
|
Algorithms | 2 | 2020 | 14158 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2010 | 631 | 0.020 |
Why?
|
Animals | 4 | 2024 | 169418 | 0.020 |
Why?
|
Mass Screening | 1 | 2023 | 5455 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2012 | 1139 | 0.020 |
Why?
|
Body Weight | 1 | 2017 | 4630 | 0.020 |
Why?
|
Bone and Bones | 1 | 2017 | 2589 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2019 | 3611 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2009 | 751 | 0.020 |
Why?
|
Human Genome Project | 1 | 2006 | 202 | 0.020 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2006 | 310 | 0.020 |
Why?
|
Los Angeles | 1 | 2006 | 245 | 0.020 |
Why?
|
Reference Values | 1 | 2012 | 4941 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 2826 | 0.010 |
Why?
|
Up-Regulation | 1 | 2013 | 4138 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2010 | 3103 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2009 | 1749 | 0.010 |
Why?
|
Loss of Heterozygosity | 1 | 2006 | 663 | 0.010 |
Why?
|
Introns | 1 | 2006 | 970 | 0.010 |
Why?
|
Vitamins | 1 | 2012 | 1638 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10865 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14480 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2015 | 65409 | 0.010 |
Why?
|
Gene Frequency | 1 | 2009 | 3615 | 0.010 |
Why?
|
California | 1 | 2006 | 1444 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 8051 | 0.010 |
Why?
|
Exons | 1 | 2006 | 2392 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2010 | 3234 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6091 | 0.010 |
Why?
|
Genomics | 1 | 2015 | 5909 | 0.010 |
Why?
|
Mental Disorders | 1 | 2019 | 6879 | 0.010 |
Why?
|
Young Adult | 1 | 2025 | 60045 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36840 | 0.010 |
Why?
|
Population Surveillance | 1 | 2006 | 2601 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2010 | 10494 | 0.010 |
Why?
|
Base Sequence | 1 | 2004 | 12428 | 0.010 |
Why?
|
Genome, Human | 1 | 2006 | 4453 | 0.010 |
Why?
|
MicroRNAs | 1 | 2009 | 3805 | 0.010 |
Why?
|
Computer Simulation | 1 | 2006 | 6278 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15965 | 0.010 |
Why?
|
Mutation | 1 | 2010 | 30243 | 0.000 |
Why?
|